GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Total Long-Term Liabilities

ENCell Co (XKRX:456070) Total Long-Term Liabilities : ₩4,434 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. ENCell Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₩4,434 Mil.


ENCell Co Total Long-Term Liabilities Historical Data

The historical data trend for ENCell Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Total Long-Term Liabilities Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
5,256.05 2,104.29 4,151.93 3,222.37 4,888.12

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,222.37 2,758.74 2,861.78 4,888.12 4,433.58

ENCell Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


ENCell Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of ENCell Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ENCell Co Business Description

Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines